(Q45738851)

English

Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice

scientific article published in February 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

attenuated vaccine

1 reference

based on heuristic

inferred from title

author name string

Fló J

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Tisminetzky S

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Baralle F

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

language of work or name

0 references

publication date

1 February 2001

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

13-14

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1772-1782

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA immunization against experimental genital herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Herpes simplex virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Live attenuated Salmonella: a paradigm of mucosal vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral somatic transgene vaccination using attenuated S. typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Genital herpesvirus hominis infection in mice. I. Development of an experimental model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Priming or tolerization of the B- and Th2-dependent immune response by the oral administration of OVA-DNP is determined by the antigen dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900375-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(00)00375-3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45738851&oldid=2079864546"